Ricin and Abrin as Possible Agents of Bioterror

Plant toxins – ricin and abrin, obtained in a purified form from the beans of the castor bean and Abrus precatorius respectively, are considered by Western experts as potential damaging agents of a biological nature. The purpose of this work is to consider the danger of using ricin and abrin as agents of biological terrorism, as well as to assess the existing approaches and means for identifying these toxins, treating the intoxication caused by them, as well as the level of development of vaccine preparations. Both toxins have a similar molecular structure and mechanism of action. They consist of two subunits – A and B, resistant to high temperatures and extreme pH values. The mechanism of their damaging action is based on irreversible inhibition of the process of protein synthesis. The LD₅₀ of ricin for humans, according to various sources, is 3 µg/kg for inhalation and intravenous intake, 22–25 µg/kg for enteral intake, and about 500 µg/kg for subcutaneous intake. Abrin is more toxic than ricin, with an LD₅₀ for humans ranging from 0.1 µg/kg to 1 µg/kg depending on the route of entry. In case of enteral poisoning with ricin and abrin, the victims develop symptoms of gastroenteritis within a few hours: nausea, vomiting and pain in the abdominal cavity and chest, diarrhea. Bleeding from various parts of the gastrointestinal tract may be present. In future, general intoxication symptoms (headache, weakness, fever) and symptoms of multiple organ damage (acute renal failure and acute liver failure) develop. In the terminal stage, symptoms of vascular shock and vascular collapse are expressed. Death usually occurs on the third day or later. Cases of the use of ricin and abrin for criminal and terrorist purposes are described in the article. The main approaches and modern means of indication, means of treating ricin and abrine intoxication, as well as the state of development of vaccine preparations are shown. The given data show that the danger of these toxins as damaging agents is underestimated in Russia. It is necessary to develop diagnostic test systems that allow early detection of intoxication with plant toxins in the affected and the toxins themselves on environmental objects, as well as specific means for the treatment and prevention of acute poisoning with ricin and abrin.

1. Onishenko G.G., Sandahchiev L.S., Netesov S.V., Martiniyk R.A. Bioterrorism: national and global threat // Journal of the Russian Academy of Science. 2003. V. 73(3). P. 195–204 (in Russian).

2. Rotz L.D., Khan A.S., Lillibridge S.R. et al. Public Health assessment of potential biological terrorism agents // Emerg. Infect. Dis. 2002. V. 8. № 2. Р. 225–230. https://doi.org/10.3201/eid0802.010164

3. Green M.S., Le Duc J., Cohen D., Franz D.R. Confronting the threat of bioterrorism: realities, challenges, and defensive strategies // Lancet Infect. Dis. 2019. V. 19. № 1. P. e2–e13. https://doi.org/10.1016/S1473-3099(18)30298-6

4. Chen H.Y., Foo L.Y., Loke W.K. Abrin and ricin: understanding their toxicity, diagnosis, and treatment / Eds. Gopalakrishnakone P., BalaliMood M., Llewellyn L., Singh B.R. Biological Toxins and Bioterrorism // Toxinology. 2015. Р. 79-102. https://doi.org/10.1007/978-94-007-5869-8_1

5. Janik E., Ceremuga M., Saluk-Bijak J., Bijak M. Biological toxins as the potential tools for bioterrorism // Intern. J. Mol. Sci. 2019. V. 20. P. 1181. https://doi.org/10.3390/ijms20051181

6. Olsnes S., Refsnes K., Christensen T.B., Pihl A. Studies on the structure and properties of the lectins from Abrus precatorius and Ricinus communis // Biochim. Biophys. Acta. 1975. V. 405. № 1. P. 1–10. https://doi.org/10.1016/0005-2795(75)90308-6

7. Tam C.C., Henderson T.D., Stanker L.H. et al. Abrin toxicity and bioavailability after temperature and pH treatment // Toxins. 2017. V. 9. P. 320. https://doi.org/10.3390/toxins9100320

8. Bigalke H., Ruinmel A. Medical aspects of toxin weapons // Toxicology. 2005. V. 214. P. 210–220.

9. Maman M., Yehezkelii Y. Ricin: A Possible noninfectious biological weapon. in bioterrorism and infectious agents: a new dilemma for the 21st Century. Boston: Springer, 2005. P. 205–216.

10. Patel V.R., Dumancas G.G., Kasi Viswanath L.C. et al. Castor oil: properties, uses, and optimization of processing parameters in commercial production // Lipid Insights. 2016. V. 9. P. 1–12. https://doi.org/10.4137/LPI.S40233

11. Griffiths G.D. Understanding ricin from a defensive view point // Toxins. 2011. V. 3. P. 1373–1392. https://doi.org/10.3390/toxins31113731

12. Zheng J., Zhao C., Tian G., He L. Rapid screening for ricin toxin of letter papers using surface enhanced Raman spectroscopy // Talanta. 2017. V. 162. P. 552–557. https://doi.org/10.1016/j.talanta.2016.10.052

13. Zhou Y., Tian X.L., Li Y.S. et al. Development of a monoclonal antibody-based sandwich-type enzyme-linked immunosorbent assay (ELISA) for detection of abrin in food samples // Food Chem. 2012. V. 135. P. 2661–2665. https://doi.org/10.1016/j.foodchem.2012.07.047

14. Gill D.M. Bacterial toxins: a table of lethal amounts // Microbiol. Rev. 1982. V. 46. № 1. P. 86–94. https://doi.org/10.1128/mr.46.1.86-94.1982.

15. Franz D., Jaax N. Ricin toxin // Medical aspects of chemical and biological warfare. Textbook of military medicine / Specialty eds. Sidell F.R., Takafuji E.T., Franz D.R. Washington. 1997. P. 631–642.

16. Medical aspects of chemical and biological warfare. Textbook of military medicine / Specialty eds. Sidell F.R., Takafuji E.T., Franz D.R. Washington. 1997. 721 p.

17. Supotnitskiy M.V. Biological war. Introduction in epidemiology of artificial processes and biological damages: monography. Moscow: «Kafedra», «Russian panorama». 2013. 1136 p. (in Russian).

18. Sadov A.A., Potetnya K.M. Obtaining and using of castor (ricin’s) oil in BRICKS countries // Youth and Science. 2018. № 3. P. 89 (in Russian).

19. Lin J.-Y., Liu S.-Y. Studies on the antitumor lectins isolated from the seeds of Ricinus communis (castor bean) // Toxicon. 1986. V. 24. № 8. P. 757–765. https://doi.org/10.1016/0041-0101(86)90100-5

20. Bucaretchi F., Borrasca-Fernandes C.F., Prado C.C. et al. Near-fatal poisoning after ricin injection // Clin. Toxicol. (Phila). 2021. V. 59. № 2. P. 158–168. https://doi.org/10.1080/15563650.2020.1771358

21. Abbes M., Montana M., Curti C., Vanelle P. Ricin poisoning: a review on contamination source, diagnosis, treatment, prevention and reporting of ricin poisoning // Toxicon. 2021. V. 195. P. 86–92. https://doi.org/10.1016/j.toxicon.2021.03.004

22. Bozza W.P., Tolleson W.H., Rivera Rosado L.A., Zhang B. Ricin detection: tracking active toxin // Biotechnol. Advances. 2015. V. 33. P. 117–123. https://doi.org/10.1016/j.biotechadv.2014.11.012

23. Smart J.K. History of chemical and biological warfare: an american perspective. Medical aspects of chemical and biological warfare. Part I: warfare, weaponry and the casualty. Washington. 1997. P. 9–86.

24. Alhamdani M., Brown B., Narula P. Abrin poisoning in an 18-month-old child // Am. J. Case Rep. 2015. V. 16. P. 146–148. https://doi.org/10.12659/AJCR.892917.

25. Huang J., Zhang W., Li X. et al. Acute abrin poisoning treated with continuous renal replacement therapy and hemoperfusion successfully: a case report // Medicine (Baltimore). 2017. V. 96. № 27. P. e7423. https://doi.org/10.1097/MD.0000000000007423.

26. Sahoo R., Hamide A., Amalnath S.D., Narayana B.S. Acute demyelinating encephalitis due to Abrus precatorius poisoning-complete recovery after steroid therapy // Clin. Toxicol. (Phila). 2008. V. 46. № 10. P. 1071– 1073. https://doi.org/10.1080/15563650802334671

27. Horowitz B.Z., Castelli R., Hughes A. et al. Massive fatal overdose of abrin with progressive encephalopathy // Clin. Toxicol. (Phila). 2020. V. 58. № 5. P. 417–420. https://doi.org/10.1080/15563650.2019.1655150

28. Rinner G.R., Watkins S.A., Shirazi F.M. et al. Fatal abrin poisoning by injection // Clin. Toxicol. (Phila). 2021. V. 59. № 2. P. 169–171. https://doi.org/10.1080/15563650.2020.1771360

29. Onishenko G.G., Smolenskiy V.J., Ejlova E.B. et al. Conceptual basis of biological safety. Part I. // Journal of the Russian Academy of Medical Science. 2013. V. 10. P. 4–13 (in Russian).

30. Saxena N., Phatak P., Chauhan V. Differential toxicity of abrin in human cell lines of different organ origin // Toxicol. In Vitro. 2022. V. 78. P. 105250. https://doi.org/10.1016/j.tiv.2021.105250

31. Isenberg S.L., Carter M.D., Miller M.A. et al. Quantification of ricinine and abrine in human plasma by HPLC-MS/MS: biomarkers of exposure to ricin and abrin // J. Anal. Toxicol. 2018. V. 42. № 9. P. 630–636. https://doi.org/10.1093/jat/bky040

32. Behnaq M.H., Karami A., Choopani A. Development of PCR-based method for rapid detection of abrin gene // J. Appl. Biotechnol. Rep. 2016. V. 3. № 3. P. 473–476.

33. Phatak P., Chauhan V., Dhaked R.K. et al. E-N- (2-acetyl-phenyl)-3-phenyl-acrylamide targets abrin and ricin toxicity: hitting two toxins with one stone // Biomed Pharmacother. 2021. V. 143. P. 112134. https://doi.org/10.1016/j.biopha.2021.112134

34. Rong Y., Pauly M., Guthals A. et al. A humanized monoclonal antibody cocktail to prevent pulmonary ricin intoxication // Toxins (Basel). 2020. V. 12. № 4. P. 215. https://doi.org/10.3390/toxinsl2040215

35. Peng J., Wu J., Shi N., et al. A novel humanized anti-abrin a chain antibody inhibits abrin toxicity in vitro and in vivo // Front. Immunol. 2022. V. 13. P. 831536. https://doi.org/10.3389/fimmu.2022.831536

36. Castelletti D., Fracasso G., Righetti S. et al. A dominant linear В-cell epitope of ricin А-chain is the target of a neutralizing antibody response in Hodgkin’s lymphoma patients treated with an antiCD25 immunotoxin // Clin. Exp. Immunol. 2004. V. 136. P. 365–372. https://doi.org/10.1111/j.1365-2249.2004.02442.x

37. Colombatti M., Johnson V.G., Skopicki H.A., et al. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin // J. Immunol. 1987. V. 138. P. 3339–3344.

38. McGuinness C.R., Mantis N.J. Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin В subunit // Infect. Immun. 2006. V. 74. P. 3463–3470. https://doi.org/0.1128/IAI.00324-06

39. O'Hara J.M., Yermakova A., Mantis N.J. Immunity to ricin: fundamental insights into toxinantibody interactions // Curr. Top. Microbiol. Immunol. 2012. V. 357. P. 209–241. https://doi.org/10.1007/822011193

40. Zhang T., Kang L., Gao S. et al. Truncated abrin A chain expressed in Escherichia coli: a promising vaccine candidate // Hum. Vaccin. Immunother. 2014. V. 10. № 9. P. 2648–2655. https://doi.org/10.4161/hv.29645

41. Wang J., Gao S., Xin W. et al. A novel recombinant vaccine protecting mice against abrin intoxication // Hum. Vaccin. Immunother. 2015. V. 11. № 6. P. 1361–1367. https://doi.org/10.1080/21645515.2015.1008879

42. Gal Y., Sapoznikov A., Falach R. et al. Equal neutralization potency of antibodies raised against abrin subunits // Antibodies (Basel). 2020. V. 9. № 1. P. 4. https://doi.org/10.3390/antib9010004